Celebrities who have spoken openly about Ozempic use

Sharon Osbourne has been remarkably open about her Ozempic journey, detailing both significant weight loss and subsequent regrets about becoming 'too thin.' Her candidness provides a crucial cautionary perspective on the drug's powerful effects and potential downsides.

Amy Schumer's experience with Ozempic was marked by severe side effects, leading her to discontinue use and advocate for transparency among celebrities. Her story offers a vital counter-narrative to purely positive testimonials, emphasizing the drug's potential drawbacks.

Tracy Morgan openly credited Ozempic for his weight loss, providing a straightforward and positive testimonial about its effectiveness in appetite suppression. His continued use offers a perspective of successful management with the medication.

Chelsea Handler's experience highlights concerns about the casual prescription of Ozempic, as she was unknowingly given it by her doctor. Her decision to stop due to nausea and a desire to maintain her appetite underscores the importance of informed consent and personal choice.

Elon Musk's high-profile admission of using Ozempic significantly amplified public awareness and discussion around the drug. His influence brought the conversation about GLP-1s to a broader, more mainstream audience.

Rebel Wilson used Ozempic to help maintain her weight after a significant weight loss journey, offering a perspective on the drug as a maintenance tool. She also defended its use, particularly for managing cravings, adding nuance to the public discourse.

Oprah Winfrey's influential voice and personal journey with weight loss lend significant credibility and visibility to the discussion of GLP-1 medications. Her description of it as a 'tool' for managing weight without yo-yoing resonates with many.

Stephen Fry's experience with Ozempic began with 'astonishing' results but ended due to severe side effects, including frequent vomiting. His story underscores that while effective for some, the drug's adverse reactions can be debilitating, leading to discontinuation.

Serena Williams' advocacy and partnership with a GLP-1 company highlight the growing acceptance and normalization of these medications for weight management, even among athletes. Her openness helps destigmatize their use.

Andy Cohen's experience with 'micro-dosing' a GLP-1 medication offers insight into different approaches to using these drugs for weight management. His success in losing 25 pounds by managing cravings and encouraging discipline provides a unique perspective.

Charles Barkley's positive experience with Mounjaro, leading to over 50 pounds of weight loss, adds a prominent sports figure's testimonial to the discussion. His story highlights the drug's potential benefits for long-term weight struggles.

Chrissy Teigen's transparency about using a GLP-1 medication to lose weight after a miscarriage adds a relatable and sensitive dimension to the discussion. Her emphasis on honesty regarding her health resonates with many.

Brooks Nader's experience highlights the professional pressures some celebrities face and the complex emotional relationship with these drugs. Her mixed feelings about Ozempic, calling it a 'crutch' while acknowledging its career benefits, offer a nuanced view.

Amanda Bynes' very recent public statements and appearance make her a current and highly relevant figure in the Ozempic discussion, particularly concerning societal pressures on celebrities. Her openness about feeling healthier and more confident adds to the ongoing dialogue.